Some literature data suggested that PD-NECs could be subdivided into two prognostic distinct categories based on the Ki67 LI cut-off of 55%, with a better prognosis in patients with a tumor with a Ki67 LI <55%, showing an intermediate behavior between the G3 NETs and the typical NECs [5,6]. This evidence concerns the gene MKI67 and neoplasm.